FindMyKOL
Clinical trialNCT00553813TerminatedPhase 2Interventional

A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic Cancer

SponsorCortice Biosciences, Inc.Enrollment23Pancreatic Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of the study is to assess the activity of TPI 287 as single agent therapy for patients with advanced, unresectable pancreatic cancer after failure of gemcitabine-containing therapy. Activity of TPI 287 will be determined by the 6-month survival rate.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Spain
  • Hospital Madrid

    Madrid, Spain

United States
  • Desert Hematology Oncology Medical Group, Inc.

    Rancho Mirage, California, United States

  • Sidney Kimmel Comprehensive Cancer Center - Johns Hopkins University

    Baltimore, Maryland, United States

  • Center for Cancer and Blood Disorders

    Bethesda, Maryland, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

TPI-287
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2007
Primary completion
30 Sept 2009
Completion
30 Apr 2010
Last update posted
22 Jan 2014
Registered enrollment
23
Registry id
NCT00553813
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.